Modified streptolysin O

US11767349B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11767349-B2
Application numberUS-201716304962-A
CountryUS
Kind codeB2
Filing dateMay 26, 2017
Priority dateMay 27, 2016
Publication dateSep 26, 2023
Grant dateSep 26, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides streptolysin O containing a polypeptide comprising an amino acid sequence having deletion of a polypeptide extending from a lysine residue at position 2 of SEQ ID NO: 1 to any of an alanine residue at position 31, a glutamate residue at position 32, a serine residue at position 33, and an asparagine residue at position 34, and also having deletion of any of an isoleucine residue at position 465 to an alanine residue at position 472 of SEQ ID NO: 1 and all of the subsequent amino acid residues, as well as variants thereof and related DNA, vectors, transformants, and methods of use thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A Streptolysin O consisting of a polypeptide having one or more tags in the N-terminal or C-terminal region of an amino acid sequence selected from position 32 to position 464 of SEQ ID NO: 1, position 32 to position 466 of SEQ ID NO: 1, position 32 to position 471 of SEQ ID NO: 1, position 35 to position 464 of SEQ ID NO: 1, position 35 to position 466 of SEQ ID NO: 1, and position 35 to position 471 of SEQ ID NO: 1. 2. A crosslinked streptolysin O obtained by crosslinking the streptolysin O consisting of: (a) a polypeptide consisting of an amino acid sequence selected from position 32 to position 464 of SEQ ID NO: 1, position 32 to position 466 of SEQ ID NO: 1, position 32 to position 471 of SEQ ID NO: 1, position 35 to position 464 of SEQ ID NO: 1, position 35 to position 466 of SEQ ID NO: 1, and position 35 to position 471 of SEQ ID NO: 1, or (b) a polypeptide having one or more tags in the N-terminal or C-terminal region of the amino acid sequence shown in (a). 3. A latex particle coated with the crosslinked streptolysin O according to claim 2 . 4. An anti-streptolysin O antibody (ASO) measuring reagent comprising the latex particle according to claim 3 . 5. A latex particle coated with the streptolysin O consisting of: (a) a polypeptide consisting of an amino acid sequence selected from position 32 to position 464 of SEQ ID NO: 1, position 32 to position 466 of SEQ ID NO: 1, position 32 to position 471 of SEQ ID NO: 1, position 35 to position 464 of SEQ ID NO: 1, position 35 to position 466 of SEQ ID NO: 1, and position 35 to position 471 of SEQ ID NO: 1, or (b) a polypeptide having one or more tags in the N-terminal or C-terminal region of the amino acid sequence shown in (a). 6. An anti-streptolysin O antibody (ASO) measuring reagent comprising the latex particle according to claim 5 . 7. A method for producing the streptolysin O according to claim 1 , the method comprising culturing the transformant containing a vector incorporating the DNA that is amplified from a base sequence represented by SEQ ID NO: 3 as a template by using primers of SEQ ID NOs: 11 and 12. 8. A method for producing the streptolysin O according to claim 1 , the method comprising culturing a transformant containing a vector incorporating DNA that is either (a) DNA that encodes the polypeptide of claim 1 , or (b) DNA that is amplified from a base sequence represented by SEQ ID NO: 2 as a template by using primers selected from SEQ ID NOs: 4 and 6, SEQ ID NOs: 4 and 7, SEQ ID NOs: 4 and 8, SEQ ID NOs: 5 and 6, SEQ ID NOs: 5 and 7, and SEQ ID NOS: 5 and 8.

Assignees

Inventors

Classifications

  • C07K14/315Primary

    from Streptococcus (G), e.g. Enterococci · CPC title

  • Streptococcus (G) · CPC title

  • Immunoglobulins · CPC title

  • the carrier being a synthetic polymer · CPC title

  • having a known sequence of two or more amino acids, e.g. glutathione · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11767349B2 cover?
The invention provides streptolysin O containing a polypeptide comprising an amino acid sequence having deletion of a polypeptide extending from a lysine residue at position 2 of SEQ ID NO: 1 to any of an alanine residue at position 31, a glutamate residue at position 32, a serine residue at position 33, and an asparagine residue at position 34, and also having deletion of any of an isoleucine …
Who is the assignee on this patent?
Toyo Boseki
What technology area does this patent fall under?
Primary CPC classification C07K14/315. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).